S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens‐Johnson syndrome and toxic epidermal necrolysis) – Part 2: Supportive therapy of EN in the acute and post‐acute stages
Maren Paulmann(University Medical Center Freiburg), Alexander Nast(Humboldt-Universität zu Berlin), Annette Stolle(Klinikum Ludwigshafen), Christina Schut(Justus-Liebig-Universität Gießen), Katharina Boch(University of Lübeck), Lars E. French(University of Miami), Bettina Wedi(Medizinische Hochschule Hannover), Heike L. Rittner(Universitätsklinikum Würzburg), Johannes M. Weiss(University Hospital Ulm), Ruben Heuer(Humboldt-Universität zu Berlin), Marcus Lehnhardt(BG University Hospital Bergmannsheil Bochum), Nicos Marathovouniotis(University Hospital Cologne), Stefan Schnitzler(RWTH Aachen University), Philipp Mandel(Ludwig-Maximilians-Universität München), Philip Maier(University Medical Center Freiburg), Maja Mockenhaupt(University Medical Center Freiburg), Katharina Rall(University Children's Hospital Tübingen), Anja M. Boos(RWTH Aachen University), Silke Hofmann(Helios Universitätsklinikum Wuppertal), Frank Sander(Unfallkrankenhaus Berlin), Yvonne Liß, Marie Pradeau(Humboldt-Universität zu Berlin), Hans Mittelviefhaus(University of Freiburg), Artem Vorobyev(University of Lübeck), Jochen Gille(Klinikum St. Georg), Uwe Pleyer(Humboldt-Universität zu Berlin), Mirjana Ziemer(University Medical Center), Verena Gundlach(Helios Klinikum Krefeld), Finnja Marlok, Maximilian Zepp(University of Kaiserslautern), Björn Behr(BG University Hospital Bergmannsheil Bochum), P. Höger(Universität Hamburg), Knut Brockow(Technical University of Munich), Siegbert Rieg(University Medical Center Freiburg), Thorsten Annecke(Witten/Herdecke University), Bernd Hartmann(Unfallkrankenhaus Berlin), Tobias Klein(University Hospital Cologne)
Cited by 12
Related Papers
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
|Science|1996|1.3k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
Definition of treatment goals for moderate to severe psoriasis: a European consensus
|Archives of Dermatological Research|2010|892